HOME >> BIOLOGY >> NEWS
Thinking small: Texas A&M team creates lab-on-a-chip

COLLEGE STATION, Jan. 14, 2005 - Imagine an entire chemistry laboratory reduced to the size of a postage stamp. It could happen.

While others may think big, Texas A&M University physicists Don Naugle and co-worker Igor Lyuksyutov are thinking small - as in micro small. They have successfully managed to levitate micron-sized fluids using magnets, which could lead to new advances in medicine, chemistry, chemical engineering and other related fields.

By using small magnets on a postage-stamp sized chip, Naugle and Lyuksyutov have managed to move and merge tiny levitating droplets and crystals and to control the orientation of the levitating crystals.

The droplets used were as small as bacteria or 100 times smaller than a human hair, and up to one billion times smaller in volume than has been demonstrated by conventional methods.

Their work was recently published in Applied Physics Letter and featured in several science journals. Their research is funded by The Robert A. Welch Foundation and National Science Foundation grants.

"It might be possible to do the same thing with a large number of fluids, chemicals or even a virus," Naugle explains.

"The Texas A&M team has managed to move and levitate several substances, including alcohol solutions, oils, some types of powders and even red blood cells and bacteria. It could be theoretically possible to reduce an entire chemistry lab to a few postage-stamp sized chips.

"Try to picture individual chemical beakers (droplets) being merged into other chemical beakers. That's the principal involved here."

Naugle calls the method a "lab on a chip" and says the possibilities are exciting.

"The lab-on-a-chip device levitates and manipulates diamagnetic objects, which are very weakly repelled by magnets," he notes.

"These include living tissue and other objects and substances you don't think of as being magnetic."

The new procedures could be appl
'"/>

Contact: Keith Randall
kr@univrel.tamu.edu
979-845-4644
Texas A&M University
14-Jan-2005


Page: 1 2

Related biology news :

1. Thinking big about things small
2. Thinking with the spinal cord?
3. Thinking the pain away? Study shows the brains painkillers may cause placebo effect
4. University of Texas researcher earns APS Bowditch award
5. Transport interrupted -- Texas A&M biologists trace cause of early blindness to tissue defect
6. Got cotton? Texas researchers discovery could yield protein to feed millions
7. Bee genome information housed at Texas A&M University
8. Patchwork strategies may be best for restoring Texas rangelands
9. Texas researchers casting for answers to stop algae problem in Texas lakes
10. Fire ant-attacking fly spreading rapidly in Texas
11. Imported pollution tied to poor air quality in Texas in 2004

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Thinking small Texas team creates lab chip

(Date:5/21/2013)... largest gathering of biomass experts , Where? ... When? 03-07 June 2013 , ... research, resource assessment, market and policy developments, manufacturing and ... world and benefiting from its 2013 edition from a ... than 60 countries, more than 240 plenary and oral ...
(Date:5/21/2013)... epigenetic modifications, which alter the way genes function ... be detected in the blood of pregnant women ... to foretell depression in the weeks after giving ... become debilitating. , The findings of the small ... in the journal Molecular Psychiatry . , ...
(Date:5/20/2013)... the effect of physical education (PE) on child weight, ... increasing the amount of time that elementary schoolchildren spent ... The study represents some of the first evidence of ... is forthcoming in the Journal of Health Economics ... can be viewed at: http://www.sciencedirect.com/science/article/pii/S0167629613000556 , The ...
Breaking Biology News(10 mins):21st European Biomass Conference and Exhibition 221st European Biomass Conference and Exhibition 321st European Biomass Conference and Exhibition 4Genetic predictors of postpartum depression uncovered by Hopkins researchers 2Genetic predictors of postpartum depression uncovered by Hopkins researchers 3Gym class reduces probability of obesity, study finds for first time 2
(Date:5/21/2013)... Wisc. (PRWEB) May 21, 2013 ... parts distributor , will be exhibiting for the ... Advancement of Medical Instrumentation (AAMI) 2013 Conference and ... purchase, support, distribute, and manufacture healthcare technologies. This ... in Long Beach, California. , The three-day ...
(Date:5/21/2013)... NC (PRWEB) May 21, 2013 ... financial services company for clinical trials, announced today ... Spend Solutions, LLC. Clinverse’s ClinPay® FLS eClinical ... investigator payment process. SpendMD ™, Aggregate ... complete solution for tracking and reporting transfer of ...
(Date:5/21/2013)... Canada (PRWEB) May 21, 2013 ... is a strong push within the industry to ... and Manufacturing Organizations and pharma companies often means ... frames. , Microtablets, developed in collaboration with Sensidose ... effective outsourcing can bring products to market sooner. ...
(Date:5/21/2013)... , May 21, 2013  MacroGenics, Inc. today ... of margetuximab (MGAH22), an Fc-modified chimeric monoclonal antibody ... the HER2 oncoprotein," will be presented at the ... Clinical Oncology during the Developmental Therapeutics - Immunotherapy ... 4:15 – 4:30 PM.  The presentation will describe ...
Breaking Biology Technology:Alpha Source, Inc. to Exhibit at the AAMI 2013 Conference and Expo 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 3The Development of an Innovative Microtablet Dosage Form, a Success Story: Live Webinar Hosted by Xtalks 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3
Cached News: